Candel Therapeutics

• locale

  United States

• market

  STOCKS

• industry

  Biotechnology

• website

  www.candeltx.com/

• ipo date

  Jul 27, 2021

Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.